Aspirin

      -Effect of Aspirin Dose on Platelet Reactivity in Diabetic Patients by Dr. Paul A. Gurbel

Coronary Revascularization in Diabetic Patients

      -Optimizing Outcomes in 2007 by Dr. David J. Cohen

Diabetic Dyslipidemia

      -Overview

Drug-Eluting and Bare Metal Stenting for Diabetes Mellitus

      -Results from the Mass-DAC Registry by Dr. Pallav Garg

Rosiglitazone's Effect on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

      -Alternative Interpretations of the Evidence by Dr. George Diamond and Dr. Sanjay Kaul

(Return to Contents)

Clinical Trials

ADVANCE: Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Released Control Evaluation

      -A Randomised Trial of Routine Blood Pressure Lowering Among 11,140 Patients with Type 2 Diabetes

DIABETES I: DIABETes and sirolimus Eluting Stent

      -Long-term Follow-up of the DIABETES I Trial by Dr. P Jiménez-Quevedo

DREAM: Diabetes REduction Assessment with ramipril and rosiglitazone Medication

      -Trial Overview

EMERALD: Limbs International Medical Buflomedil

      -Diabetic Substudy by Dr. Steve Marso

FIELD: Fenofibrate Intervention and Event Lowering in Diabetes

      -Trial Overview by Dr. Anthony Keech (AHA 2005)

JPAD: The Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes

      -Efficacy of Low-Dose Aspirin Therapy for the Primary Prevention of Atherosclerotic Events in Type 2 Diabetic Patients by Dr. Hisao Ogawa (AHA 2005)

OPTIMUS: Optimizing Antiplatelet Therapy in Diabetes Mellitus

      -Trial Results by Dr. Dominick J. Angiolillo (2007)

OPTIMUS-2: Optimizing Anti-Platelet Therapy in Diabetes Mellitus-2

      -Trial Results by Dr. Dominick J. Angiolillo (CRT 2008)

PIOSTAT: Anti-Inflammatory Effects of Pioglitazone and/or Simvastatin in High Cardiovascular Risk Patients With Elevated High Sensitivity C-Reactive Protein

      -Trial Overview by Dr. Markolf Hanefeld (2007)

PROACTIVE: Prospective Pioglitazone Clinical Trial in Macrovascular Events

      -Trial Overview by Dr. Ele Ferrannini (2005)

Rimonabrant

      -A New Approach to Multiple Cardiometabolic Risk Factors (2005)

UKPDS: The UK Prospective Diabetes Study

      -Overview of Treatments for Type II Diabetes

(Return to Contents)

Who Are We?    Slide Downloading Policy   Financial Disclosure    We Do Not Promote Off Label Product Use    Copyright    Source of Slides    Editorial Policy    Links Policy    Privacy Policy   Access    CME Programs